BCBA/DOCU (BCBA/DOCU)

Buenos Aires Stock Exchange: BCBA/DOCU · ARS

ARS 6,270

+130.16 (+2.1%)· Recorded snapshot

Market cap	24T
Revenue (ttm)	5T
Net income (ttm)	491.4B
EPS (ttm)	ARS 115
P/E (trailing)	54.4x
P/E (forward)	16.8x
Volume	3,894

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5T
Net income (ttm): 491.4B
EPS (ttm): ARS 115
P/E (trailing): 54.4x
P/E (forward): 16.8x
Market cap: 24T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/E54.4

P25 n/aP50 n/aP75 n/a

ROE17.8

P25 n/aP50 n/aP75 n/a

ROIC26.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/DOCU indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-12-03
Employees	7,044
Employees change	206
Employees growth	3.01%
Enterprise value	ARS 23.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	January
Founded	2003
Industry	Software - Application
Is primary listing	No
ISIN number	ARBCOM4603H9
Last earnings date	2026-09-03
Last refreshed	2026-10-29
Market cap	ARS 24T
Next earnings date	2026-12-03
Price	ARS 6,270.00
Price currency	ARS
Sector	Technology
SIC code	7370
Stock price date	2026-10-28
Symbol	bcba/DOCU
Website	https://www.docusign.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	57.08x
Earnings yield	1.84%
EV/Earnings	47.02x
EV/EBIT	37.39x
EV/EBITDA	32.09x
EV/FCF	12.95x
EV/Sales	4.47x
FCF / EV yield	7.72%
FCF yield	7.43%
Forward P/E	16.84x
Graham number	1388.62805
Graham upside	-77.85%
P/(FCF - SBC) ratio	27.24x
P/(OCF - SBC) ratio	22.48x
P/B ratio	9.38x
P/E ratio	54.43x
P/FCF ratio	13.46x
P/OCF ratio	12.18x
P/S ratio	4.8x
Price / tangible book value	13.35x
Price/EBITDA ratio	36.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	11.96%
EBITDA margin	13.14%
Effective tax rate	24.98%
FCF margin	34.44%
Gross margin	79.61%
Operating margin	11.96%
Pretax margin	13.08%
Profit margin	9.82%
Profit per employee	ARS 69.8M
Profitable quarters	15
Profitable years	3
Revenue per employee	ARS 710.7M
ROA	6.35%
ROA (5Y)	1.45%
ROCE	20.23%
ROE	17.8%
ROE (5Y)	9.46%
ROIC	26.08%
ROIC (5Y)	8.4%
SBC / revenue	18.03%
Tax / revenue	3.27%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	23.26%
EPS growth (Q)	33.33%
EPS growth (QoQ)	0%
EPS growth quarters	4
EPS growth years	0
FCF growth	28.06%
FCF growth (Q)	35.89%
FCF growth (QoQ)	2.18%
FCF growth 3Y	29.85%
FCF growth 5Y	26.72%
Gross profit growth	8.71%
Gross profit growth (Q)	9.74%
Gross profit growth 3Y	7.82%
Gross profit growth 5Y	14.09%
Net income growth	17.43%
Net income growth (Q)	23.42%
Net income growth (QoQ)	-0.62%
Net income growth quarters	4
Net income growth years	0
OCF growth	27.31%
OCF growth (Q)	35.95%
OCF growth (QoQ)	4%
OCF growth 3Y	27.8%
OCF growth 5Y	25.05%
Operating income growth	61.25%
Operating income growth (Q)	80.33%
Operating income growth 3Y	123.76%
Revenue growth	8.59%
Revenue growth (Q)	9.38%
Revenue growth (QoQ)	5.48%
Revenue growth 3Y	8.19%
Revenue growth 5Y	13.37%
Revenue growth quarters	34
Revenue growth years	10

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -186.8B
Depreciation and amortization	ARS 61.1B
EBIT	ARS 598.8B
EBITDA	ARS 657.8B
EPS	ARS 115.20
Financing cash flow	ARS -1.9T
Free cash flow	ARS 1.8T
Free cash flow minus SBC	ARS 882B
Gross profit	ARS 4T
Income taxes	ARS 163.7B
Investing cash flow	ARS -175.1B
Net cash flow	ARS -105.4B
Net income	ARS 491.4B
Operating cash flow minus SBC	ARS 1.1T
Operating income	ARS 598.8B
Revenue	ARS 5T
Stock-based compensation	ARS 902.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.28
Book value per share	ARS 13,602.88
Debt / EBITDA	0.39
Debt / equity	0.11
Debt / FCF	0.15
Goodwill	ARS 706.7B
Interest coverage	170.35
Long-term assets	ARS 3.9T
Long-term liabilities	ARS 298B
Net cash (debt)	ARS 885.6B
Net cash / market cap	3.69%
Net cash growth	-17.13%
Net debt / EBITDA	-1.35
Net debt / equity	-0.35
Net debt / FCF	-0.5
Piotroski F-Score	6
Property, plant and equipment	ARS 886.7B
Shareholders' equity	ARS 2.6T
Tangible book value	ARS 1.8T
Tangible book value per share	ARS 9,563.71
Total assets	ARS 5.9T
Total cash	ARS 1.2T
Total debt	ARS 272.7B
Total liabilities	ARS 3.3T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.85
Current assets	ARS 2T
Current liabilities	ARS 3T
Current ratio	0.64
Net working capital	ARS -2.2T
Quick ratio	0.59
Working capital	ARS -1T
Working capital turnover	-8,620.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	5.17%
Shareholder yield	5.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 3,951.55
1D price change	2.12%
1M price change	27.05%
1M total return	27.05%
1W price change	6.18%
1W total return	6.18%
1Y price change	30.15%
1Y return CAGR	30.17%
1Y total return	30.15%
20-day SMA	ARS 5,576.00
200-day SMA	ARS 3,832.16
3M price change	63.49%
3M total return	63.49%
3Y price change	319.68%
3Y return CAGR	61.28%
3Y total return	319.68%
50-day SMA	ARS 5,099.25
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 6,535.00
52-week high date	2026-10-26
52-week low	ARS 2,635.00
52-week low date	2026-02-23
5Y price change	146.41%
5Y return CAGR	19.77%
5Y total return	146.41%
6M price change	100%
6M total return	100%
All-time high	ARS 6,535.00
All-time high date	2026-10-26
All-time low	ARS 547.00
All-time low date	2022-11-09
Average true range (ATR)	ARS 211.01
Average volume	5K
Change from 52-week high	-4.06%
Change from 52-week low	137.95%
Change from all-time high	-4.06%
Change from all-time low	1,046.25%
Change from open	1.21%
Day's gap	0.9%
Dollar volume	ARS 24.4M
High price	ARS 6,275.00
Low price	ARS 6,190.00
Monthly RSI	68.87
Open price	ARS 6,195.00
Position in 52-week range	94.12%
Previous close	ARS 6,140.00
Price vs 150-day SMA	58.67%
Price vs 20-day SMA	12.45%
Price vs 200-day SMA	63.62%
Price vs 50-day SMA	22.96%
Relative volume	0.79
RSI	69.68
Sharpe ratio	0.7
Sharpe ratio (3Y)	1.09
Sharpe ratio (5Y)	0.57
Sortino ratio	1.14
Sortino ratio (3Y)	1.83
Sortino ratio (5Y)	0.91
Volume	3.9K
Weekly RSI	79.03
YTD price change	30.83%
YTD total return	30.83%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	185.8M
Shares change (QoQ)	-1.71%
Shares change (YoY)	-5.17%
Shares held by insiders	0.53%
Shares held by institutions	95.66%
Short ratio	3.9 days

Deeper analysis on BCBA/DOCU

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/DOCU report

Is a complete BCBA/DOCU research report available?

No complete published report is available for bcba/DOCU (BCBA/DOCU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/DOCU (BCBA/DOCU)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/DOCU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/DOCU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/DOCU

Frequently asked questions